Diabetes and Lung Disease: A Neglected Relationship

Area of Science:

• Pulmonary Medicine
• Endocrinology
• Systemic Inflammation

Background:

• Diabetes mellitus is a systemic disorder linked to inflammation and oxidative stress, affecting organs like kidneys and retina.
• While its impact on other organs is well-studied, the lung as a target organ for diabetes remains underexplored.

Purpose of the Study:

• To review the effects of diabetes and hypoglycemic agents on lung diseases.
• To investigate potential mechanisms linking diabetes to lung conditions such as asthma, COPD, idiopathic pulmonary fibrosis, pulmonary hypertension, and lung cancer.

Main Methods:

• Literature review of studies investigating the relationship between diabetes and lung diseases.
• Analysis of proposed mechanisms, including inflammation, oxidative stress, and vascular effects.
• Examination of the influence of specific hypoglycemic agents (e.g., metformin, insulin) on lung disease outcomes.

Main Results:

• Diabetes can significantly influence the severity and clinical course of various lung diseases.
• Epidemiological and clinical evidence establishes a link between diabetes and lung conditions, particularly asthma.

Conclusions:

• The precise mechanisms underlying the diabetes-lung association require further elucidation.
• Proposed mechanisms involve diabetes-related inflammation, proliferative effects, and micro/macrovascular changes in the pulmonary vasculature.
• Hypoglycemic drugs exhibit varied effects on lung diseases, with metformin showing potential therapeutic benefits and insulin potentially exacerbating conditions.